Navigation Links
GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
Date:4/21/2009

NEW YORK, April 21 /PRNewswire/ -- GenVault, a leading provider of room-temperature biosample transport, storage and management technologies, announced the release today of GenConnect 3.2, the newest version of its software for complete biosample management. Highlights of the release include a strategic licensing model that enables GenConnect to be integrated seamlessly into third-party informatics offerings, as well as a new customer licensing model that enables scalable enterprise-wide deployment that can be centrally administered.

GenConnect 3.2 supports the tracking of individual samples -- with either GenVault's own GenTegra(TM) tubes for purified DNA stored at room temperature, or generic tubes and vials stored in the frozen state - throughout the storage, retrieval and transport lifecycle. All data associated with storage locations and samples can be batch-uploaded to the database with a single click, making GenConnect an ideal solution for enterprise sites that need to process thousands of sample aliquots per day.

"With its rich JAVA-based API, language-independent Web Services interface, and standardized flat-file import/export capabilities, GenConnect can be seamlessly integrated with any upstream or downstream informatics packages and databases. The latest example of this is the integration of GenConnect 3.2 to GenoLogics' Biomedical Informatics product suite, as a part of our continuing partnership with GenoLogics to enable turnkey solutions for clinical and discovery research," said Dr. Dipesh Risal, Senior Product Manager for Software at GenVault. "GenConnect's client-server architecture allows for enterprise-level multi-site deployments, enabling both inter- and intra-institution connectivity; further, strict and tiered access controls built into the software means that entire networks of end-users can be administered from a centralized location. With this release, we are also rolling out a simple yet scalable licensing model that enables our customers to start small, with the option to scale-up and add more users as they derive greater value from the software."

GenConnect can accommodate the full spectrum of storage units used in biobanking, from traditional containers such as freezers and liquid nitrogen tanks, to the space saving, energy-efficient room-temperature storage options provided by GenVault. Stringent QA controls are built into the software for all Project, Subject and Sample-level data entry.

About GenVault

GenVault is a Global provider of cutting-edge technologies, for the acquisition, transportation and storage of biospecimens at ambient temperature, in the dry-state. GenConnect software, used to manage these technologies, can also be used with traditional cryogenic systems to enable mixed-phase sample management.

GenVault's technologies are environmentally friendly, space efficient alternatives to traditional sample storage systems. They reduce the carbon footprint of labs and significantly reduce energy consumption.

GenVault's systems are currently empowering over 150 pharmaceutical companies, medical centers and academic research institutions to sustainably leverage the rapidly growing genomics industry.

For more information, visit http://www.genvault.com/.

Available Topic Expert: For information on the listed expert, click appropriate link.

Dipesh Risal

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87341

CONTACT: Bret Dash, 760-268-5242, bdash@genvault.com.


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
2. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
3. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
4. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
5. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
6. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
7. GenVault Expands Scientific Advisory Board
8. GenVault Corporation Launches GenTegra(TM) DNA
9. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
10. GenVault to Present at the BIOCOM Investor Conference
11. GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage of ... newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and ... synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market ...
(Date:10/11/2017)... ... ... Personal eye wash is a basic first aid supply for any work environment, but most ... you rinse first if a dangerous substance enters both eyes? It’s one less decision, and ... unique dual eye piece. , “Whether its dirt and debris, or an acid or alkali, ...
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the ... won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to ... Experience from US2020. , US2020’s mission is to change the trajectory of STEM ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
Breaking Biology News(10 mins):